Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis

This publication has 29 references indexed in Scilit:

• Cellular response to etoposide treatment
  Cancer Letters, 2007
• Rybp, a polycomb complex-associated protein, is required for mouse eye development
  BMC Developmental Biology, 2007
• Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy
  Cancer Gene Therapy, 2007
• Genome Regulation by Polycomb and Trithorax Proteins
  Published by Elsevier ,2007
• Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway
  Journal of Cell Science, 2005
• Optimizing First-Line Treatment Options for Patients with Advanced NSCLC
  The Oncologist, 2005
• Rybp/DEDAF Is Required for Early Postimplantation and for Central Nervous System Development
  Molecular and Cellular Biology, 2005
• Cellular processing of platinum anticancer drugs
  Nature Reviews Drug Discovery, 2005
• Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing
  Cell Death & Differentiation, 2004
• Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription
  Cell Death & Differentiation, 2001